Human papillomavirus screening: Difference between revisions
Jump to navigation
Jump to search
Aysha Aslam (talk | contribs) No edit summary |
Aysha Aslam (talk | contribs) No edit summary |
||
| Line 28: | Line 28: | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
*Do not screen | *Do not screen | ||
*Grade D | *[[United states preventive services task force recommendations scheme#USPSTF Grade Definitions|Grade D recommendation]] | ||
|- | |- | ||
| style="padding: 5px 5px; background: #DCDCDC;" | Women older than 65 (who have had adequate prior screening) | | style="padding: 5px 5px; background: #DCDCDC;" | Women older than 65 (who have had adequate prior screening) | ||
Revision as of 13:48, 13 October 2016
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Aysha Anwar, M.B.B.S[2]
|
Human papillomavirus Microchapters |
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Human papillomavirus screening On the Web |
|
American Roentgen Ray Society Images of Human papillomavirus screening |
|
Risk calculators and risk factors for Human papillomavirus screening |
Overview
Screening
High risk HPV types are associated with 70% of cervical cancers in females having persistent infection.[1] Due to this strong association between HPV and cervical cancer, cervical cancer screening is recommended in all females from age 21. According to the US Preventive Services Task Force (USPSTF), specific screening guidelines for cervical cancer is described below:[2]
| Population | Recommendations |
|---|---|
| Women 21 to 65 (Pap Smear) |
|
| Women aged 30-65 |
|
| Women younger than 21 |
|
| Women older than 65 (who have had adequate prior screening) |
|
| Women after hysterectomy with removal of cervix (no h/o high grade precancer or cervical cancer) |
|
| Women before age 30 |
|
References
- ↑ http://www.cdc.gov/vaccines/pubs/pinkbook/hpv.html#epi Accessed on October 13, 2016
- ↑ Moyer VA, U.S. Preventive Services Task Force (2012). "Screening for cervical cancer: U.S. Preventive Services Task Force recommendation statement". Ann Intern Med. 156 (12): 880–91, W312. doi:10.7326/0003-4819-156-12-201206190-00424. PMID 22711081.
- ↑ Datta SD, Koutsky LA, Ratelle S, Unger ER, Shlay J, McClain T; et al. (2008). "Human papillomavirus infection and cervical cytology in women screened for cervical cancer in the United States, 2003-2005". Ann Intern Med. 148 (7): 493–500. PMID 18378945 PMID: 18378945 Check
|pmid=value (help).